Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase III, Multicenter, Randomized, Double-blind Clinical Trial to Assess the Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia

NCT06264414 is registered in ClinicalTrials.gov with EMS as lead sponsor.

NCT NCT06264414
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06264414 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase III, Multicenter, Randomized, Double-blind Clinical Trial to Assess the Efficacy and Safety of the DTT106 in the Treatment of Erectile Dysfunction Associated With Benign Prostatic Hyperplasia
Lead sponsor
EMS
Phase
Phase 3
Overall status
Not yet recruiting
Start date
February 28, 2025
Completion date
July 31, 2027
Enrollment
262 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

erectile dysfunction, prostatic hyperplasia, benign